Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2017

Pharma News, 2017

Apotex partners with Panacea Biotec to launch first-to-file Effient generic
Apotex partners with Panacea Biotec to launch first-to-file Effient generic
MUMBAI and Weston, Fla.
FDA approves 3 Lupin generics
FDA approves 3 Lupin generics
SILVER SPRING, Md.
Court clears Teva’s application for generic Uceris in patent-infringement suit
Court clears Teva’s application for generic Uceris in patent-infringement suit
JERUSALEM — A possible forthcoming generic from Teva has been cleared of a big hurdle.
States seek to expand lawsuit against generic drug-makers
States seek to expand lawsuit against generic drug-makers
Connecticut's attorney general and 45 of his colleagues are seeking to expand a federal antitrust lawsuit against generic drug-makers to include more manufacturers and medications, as well as seni...
Gene therapy protects against age-related cognitive and memory deficits
Gene therapy protects against age-related cognitive and memory deficits
Researchers from the Institute of Neurosciences at the Universitat Autònoma de Barcelona (INc-UAB) and the Vall d"Hebron Research Institute (VHIR) are the first to demonstrate th...
Alzheimer's disease might be a 'whole body' problem
Alzheimer's disease might be a 'whole body' problem
Alzheimer's disease, the leading cause of dementia, has long been assumed to originate in the brain.
AstraZeneca wins US approval for lymphoma drug
AstraZeneca wins US approval for lymphoma drug
The Food and Drug Administration on Tuesday granted accelerated approval to AstraZeneca PLC for its Calquence (KAL'-kwens) for treating patients after chemotherapy or other treatments fail...
FDA approves first GMG treatment in more than 60 years
FDA approves first GMG treatment in more than 60 years
Myasthenia gravis is a progressive autoimmune disease that leads to muscle weakness.
Ozanimod MS data brings some relief for stumbling Celgene
Ozanimod MS data brings some relief for stumbling Celgene
This week could scarcely be tougher than the last one was for Celgene (Nasdaq.
Sumitomo Dainippon gains Japan and other Asian rights to imeglimin
Sumitomo Dainippon gains Japan and other Asian rights to imeglimin
Japan’s Sumitomo Dainippon Pharma (TYO.
A Billionaire Bribed Doctors to Overprescribe Powerful Opioids 'Solely for Profit,' Prosecutors Say
A Billionaire Bribed Doctors to Overprescribe Powerful Opioids 'Solely for Profit,' Prosecutors Say
(PHOENIX) — U.
Dendreon Strengthens Executive Team with Key Management Appointments
Dendreon Strengthens Executive Team with Key Management Appointments
SEAL BEACH, Calif.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand